One signature is associated with biallelic inactivation of BRCA1 and BRCA2 (due to HR deficiency) but has also been demonstrated in breast [33] and pancreatic [34] cancers from individuals with constitutional PALB2 truncating variants. Here, PALB2 is linked to cancer.